Deep Chakrabarti @deeponco.bsky.social · 01/07/2025@alison-tree.bsky.social @ccparker.bsky.social #prostatecancer #pcsm 032
Deep Chakrabarti @deeponco.bsky.social · 13/06/2025Happy to share our review on hypo- and ultra-hypofractionation for prostate cancer radiotherapy, just published in Seminars in Radiation Oncology @alison-tree.bsky.social @harshanigreen.bsky.social Full-text link: authors.elsevier.com/a/1lFrI3lXQo... 083
Deep Chakrabarti @deeponco.bsky.social · 26/05/2025Management of Testicular Cancer @ascocancer.bsky.social doi.org/10.1200/OP-2... 020
Reposted by Deep ChakrabartiAlison Tree @alison-tree.bsky.social · 23/05/2025Excited to see the HERMES trial results in print www.sciencedirect.com/science/arti... Small trial but toxicity of 2 fractions looks promising at 24/27 Gy, no GI tox of G2 or higher out to 12 weeks @momentumstudy.bsky.social @icr.ac.uksciencedirect.comHERMES: Randomised trial of 2-fraction or 5-fraction MRI-guided adaptive prostate radiotherapyTo demonstrate safety and feasibility of 2-fraction stereotactic body radiotherapy (SBRT) for prostate cancer.This single centre, non-comparative, pha… 073
